ProShare Advisors’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$216K Sell
19,820
-3,673
-16% -$45.9K ﹤0.01% 1527
2025
Q4
$304K Buy
23,493
+2,136
+10% +$27.4K ﹤0.01% 1450
2025
Q3
$276K Sell
21,357
-3,641
-15% -$48.6K ﹤0.01% 1488
2025
Q2
$445K Sell
24,998
-3,015
-11% -$52.5K ﹤0.01% 1184
2025
Q1
$499K Sell
28,013
-7,102
-20% -$161K ﹤0.01% 1101
2024
Q4
$1.05M Buy
35,115
+8,596
+32% +$182K ﹤0.01% 888
2024
Q3
$414K Buy
+26,519
New +$481K ﹤0.01% 1258
2023
Q3
Sell
-6,872
Closed -$285K 1850
2023
Q2
$285K Sell
6,872
-439
-6% -$27.3K ﹤0.01% 1307
2023
Q1
$440K Sell
7,311
-2,738
-27% -$219K ﹤0.01% 965
2022
Q4
$737K Sell
10,049
-195
-2% -$14.7K ﹤0.01% 812
2022
Q3
$778K Buy
10,244
+625
+6% +$48.8K ﹤0.01% 778
2022
Q2
$668K Sell
9,619
-3,227
-25% -$243K ﹤0.01% 850
2022
Q1
$1.06M Sell
12,846
-4,017
-24% -$296K ﹤0.01% 897
2021
Q4
$1.27M Buy
16,863
+14,755
+700% +$1.48M ﹤0.01% 917
2021
Q3
$245K Sell
2,108
-995
-32% -$150K ﹤0.01% 1685
2021
Q2
$688K Buy
3,103
+1,506
+94% +$293K ﹤0.01% 1285
2021
Q1
$211K Buy
1,597
+79
+5% +$12.5K ﹤0.01% 2010
2020
Q4
$263K Sell
1,518
-16,215
-91% -$2.22M ﹤0.01% 1697
2020
Q3
$1.97M Buy
17,733
+1,683
+10% +$135K 0.01% 573
2020
Q2
$952K Sell
16,050
-2,654
-14% -$175K 0.01% 728
2020
Q1
$1.26M Sell
18,704
-14,475
-44% -$1.14M 0.01% 556
2019
Q4
$2.8M Sell
33,179
-3,293
-9% -$266K 0.01% 545
2019
Q3
$2.73M Buy
36,472
+728
+2% +$58.2K 0.02% 528
2019
Q2
$2.26M Sell
35,744
-4,527
-11% -$229K 0.01% 560
2019
Q1
$1.94M Buy
40,271
+981
+2% +$47.2K 0.01% 607
2018
Q4
$1.31M Sell
39,290
-7,597
-16% -$278K 0.01% 653
2018
Q3
$2.46M Sell
46,887
-695
-1% -$27.7K 0.02% 562
2018
Q2
$1.49M Sell
47,582
-1,460
-3% -$40.6K 0.01% 691
2018
Q1
$1.07M Sell
49,042
-7,676
-14% -$165K 0.01% 796
2017
Q4
$1.15M Buy
56,718
+2,620
+5% +$50.5K 0.01% 775
2017
Q3
$1.07M Buy
54,098
+3,747
+7% +$73.6K 0.01% 715
2017
Q2
$871K Sell
50,351
-1,954
-4% -$25.2K 0.01% 768
2017
Q1
$424K Sell
52,305
-13,162
-20% -$95K ﹤0.01% 1075
2016
Q4
$514K Buy
+65,467
New +$527K 0.01% 1060

Other funds holding NVCR